Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0

Movements of ABSC have indeed been strongly correlated with those of CRA, as have most of the so-called "genomics" companies -- AFFX, INCY, HGSI. The tendency of stocks in the same sector to move together isn't surprising. And Celera's victories on the sequencing event should in fact vitalize the entire industry, improving the potential content of AFFX's gene chips (which can then more-completely represent the genome) and increasing the need for ABSC's high-throughput screening technology (which promises to turn the most interesting of those newly-discovered genes into useful drugs).

What is surprising is investors' failure to distinguish among genomics stocks when news events clearly don't affect them the same way.

Case in point: the issue of gene patents. This issue doesn't unify the biotech sector, it divides it. Outside of the companies that are actually doing the sequencing (e.g. Celera and Incyte), most of the industry would love to see sequence-based gene patents be limited in scope.... Suppose the judicial system does in fact curtail the scope of gene patents, particularly those based primarily sequence information alone (rather than on insights about gene function). Such a desicion would compromise the sequence-based patents which Celera and Incyte are filing on the genes they discover. But a company like ABSC isn't in the business of patenting gene sequences -- in fact, with their GenomeScreen technology, they're in the business of discovering what genes actually do. So a challenge to sequence-based patents would likely heat up demand for Aurora's technology.... Anyway, the Clinton-Blair announcement caused a selloff in the whole genomics sector, even though many genomics companies probably would have considered it good news.

An analogy may be in the way the Judge Jackson's decision in the Microsoft case caused a selloff in the computer industry, even though most of the computer industry (outside of Microsoft) would love to see Microsoft's reign of terror curtailed.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.